Related references
Note: Only part of the references are listed.Economic burden of spinal muscular atrophy in the United States: a contemporary assessment
Marcus Droege et al.
JOURNAL OF MEDICAL ECONOMICS (2020)
Gene Therapy for Spinal Muscular Atrophy: Safety and Early Outcomes
Megan A. Waldrop et al.
PEDIATRICS (2020)
Evaluating Benefit-risk Decision-making in Spinal Muscular Atrophy: A First-ever Study to Assess Risk Tolerance in the SMA Patient Community
Rosangel Cruz et al.
CLINICAL THERAPEUTICS (2019)
High Healthcare Resource Use in Hospitalized Patients with a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1): Retrospective Analysis of the Kid's Inpatient Database (KID)
Jessica Cardenas et al.
PHARMACOECONOMICS-OPEN (2019)
Perspectives on Spinraza (Nusinersen) Treatment Study: Views of Individuals and Parents of Children Diagnosed with Spinal Muscular Atrophy
Michelle Pacione et al.
JOURNAL OF NEUROMUSCULAR DISEASES (2019)
Social participation of adult patients with spinal muscular atrophy: Frequency, restrictions, satisfaction, and correlates
Esther T. Kruitwagen-van Reenen et al.
MUSCLE & NERVE (2018)
Financial, opportunity and psychosocial costs of spinal muscular atrophy: an exploratory qualitative analysis of Australian carer perspectives
Michelle A. Farrar et al.
BMJ OPEN (2018)
Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 (SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)
Hasane Ratni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Preliminary Safety and Tolerability of a Novel Subcutaneous Intrathecal Catheter System for Repeated Outpatient Dosing of Nusinersen to Children and Adults With Spinal Muscular Atrophy
Kevin A. Strauss et al.
JOURNAL OF PEDIATRIC ORTHOPAEDICS (2018)
Laparoscopic Roux-en-Y gastric bypass vs. laparoscopic sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis of lipid effects at one year postsurgery
Elisenda Climent et al.
MINERVA ENDOCRINOLOGICA (2018)
Disease impact on general well-being and therapeutic expectations of European Type II and Type III spinal muscular atrophy patients
Francoise Rouault et al.
NEUROMUSCULAR DISORDERS (2017)
The Dilemma of Two Innovative Therapies for Spinal Muscular Atrophy
Ans T. van der Ploeg
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
J. R. Mendell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
R. S. Finkel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain
Julio Lopez-Bastida et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
The economic burden of spinal muscular atrophy
Edward P. Armstrong et al.
JOURNAL OF MEDICAL ECONOMICS (2016)
Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study
Ying Qian et al.
BMC NEUROLOGY (2015)
Understanding patient preferences and willingness to pay for hemophilia therapies
Shraddha S. Chaugule et al.
Patient Preference and Adherence (2015)
SPINAL MUSCULAR ATROPHY: DIAGNOSIS AND MANAGEMENT IN A NEW THERAPEUTIC ERA
W. David Arnold et al.
MUSCLE & NERVE (2015)
The Genetics of Spinal Muscular Atrophy: Progress and Challenges
Michelle A. Farrar et al.
NEUROTHERAPEUTICS (2015)
Sample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical Guide
Esther W. de Bekker-Grob et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2015)
COST OF ILLNESS FOR NEUROMUSCULAR DISEASES IN THE UNITED STATES
Jane Larkindale et al.
MUSCLE & NERVE (2014)
A discrete-choice experiment of United Kingdom patients′ willingness to risk adverse events for improved function and pain control in osteoarthritis
A. B. Hauber et al.
OSTEOARTHRITIS AND CARTILAGE (2013)
Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force
F. Reed Johnson et al.
VALUE IN HEALTH (2013)
Spinal Muscular Atrophy: Manifestations and Management
Addisu Mesfin et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2012)
Spinal muscular atrophy
Adele D'Amico et al.
ORPHANET JOURNAL OF RARE DISEASES (2011)
Conjoint Analysis Applications in Health-a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force
John F. P. Bridges et al.
VALUE IN HEALTH (2011)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Consensus statement for Standard of Care in Spinal Muscular Atrophy
Ching H. Wang et al.
JOURNAL OF CHILD NEUROLOGY (2007)
Large factorial designs for product engineering and marketing research applications
WF Kuhfeld et al.
TECHNOMETRICS (2005)
Share Paper
